EBM PICO - PowerPoint PPT Presentation

1 / 25
About This Presentation
Title:

EBM PICO

Description:

... cough, sputum volume and purulence diagnostic criteria for COPD ... Mortality. Treatment failure. Sputum purulence. Short-term mortality. Hospital days ... – PowerPoint PPT presentation

Number of Views:2494
Avg rating:3.0/5.0
Slides: 26
Provided by: chime5
Category:
Tags: ebm | pico | purulence

less

Transcript and Presenter's Notes

Title: EBM PICO


1
EBM - PICO
  • R1 ???

2
Basic data
  • Name ???
  • Sex male
  • Age 77 y/o
  • Chart No 20419360
  • Admission date 97 / 5 / 22

3
Chief complain
  • Acute onset of shortness of breath
  • for one day.

4
Present illness
  • This 75 y/o male had past history of (1)COPD for
    2-3 years, (2)Hypertension with Norvasc control,
    (3)BPH (4)lumber spine (L1 ) compression fracture.

5
Present illness
  • He was a heavy smoker. He had COPD with acute
    exacerbation for several times in recent years.
  • The pulmonary function test (97/02/04)) showed
    very severely obstructive ventilatory
    impairment..

6
  • He was just discharge from our ward due to
    chronic obstructive pulmonary disease with acute
    exacerbation on 97/05/20.
  • He had mild cough with whitish sputum in
  • recent days. Shortness of breath was noted
    since last night, accompanied with wheezing.
  • He also complained of nasal congestion and
    sore throat currently.
  • There was no fever, no chillness, no chest
  • pain, no hemoptysis, and no travel history.

7
  • Due to the discomfort, he went to our ER. The
    laboratory data showed leukocytosis with left
    shift and CXR showed emphysematous change over
    bilateral lower lung. No active infection or
    infiltration process could be seen.
  • Under the impression of chronic obstructive
    pulmonary disease with acute exacerbation, he was
    admitted for further survey and treatment.

8
Past / Personal history
  • Medical history
  • recurrent COPD with acute exacerbation and
    secondary infection
  • Smoking1 PPD for 50 years, quit for 2 years
  • Alcoholic drinkingdenied
  • Betel nutdenied
  • Travel history denied

9
97/5/21 ER
10
97/5/21 ER
11
PICO
  • P patient with exacerbations of chronic
  • obstructive pulmonary disease
  • I using antibiotics
  • C without antibiotics
  • O Outcome (hospital day, mortality)

12
(No Transcript)
13
Result
  • Search Results 9

14
  • Antibiotics for exacerbations of chronic
    obstructive pulmonary disease
  • (Review)
  • Ram FSF, Rodriguez-Roisin R, Granados-Navarrete
    A, Garcia-Aymerich J, Barnes NC

15
Background
  • For decades, there is an unresolved debate about
    adequate prescription of antibiotics for patients
    suffering from exacerbations of chronic
    obstructive pulmonary disease (COPD).
  • The aim of this systematic review was to analyse
    randomised controlled trials investigating the
    clinical benefit of antibiotics for COPD
    exacerbations.

16
Search strategy
  • Searched the
  • 1.Cochrane Central Register of Controlled Trials
  • (The Cochrane Library Issue 4, 2005)
  • 2.MEDLINE (1966 to December 2005)
  • 3.EMBASE (1974 to December 2005)
  • 4.Web of Science (December 2005)

17
Search strategy
  • Systematic review of randomised,
    placebo-controlled trials assessing the effects
    of antibiotics on clinically relevant outcomes in
    patients with an exacerbation.

18
Main results
  • Eleven trials with 917 patients were included.
    Ten trials used increased cough, sputum volume
    and purulence diagnostic criteria for COPD
    exacerbation.
  • It provided data for outcomes including
    mortality, treatment failure, increased sputum
    volume, sputum purulence, PaCO2, PaO2, peak flow
    and adverse events.

19
Main results
  • Antibiotic therapy regardless of antibiotic
    choice significantly reduced mortality, treatment
    failure and sputum purulence .
  • Antibiotics did not improve arterial blood gases
    and peak flow.

20
Conclusion
  • Antibiotics effectively reduce treatment failure
    and mortality rates in COPD patients with severe
    exacerbations.
  • For patients with mild to moderate
    exacerbations, antibiotics may not be generally
    indicated.
  • Further research is needed to guide antibiotic
    prescription in these patients.

21
Mortality
22
Treatment failure
23
Sputum purulence
24
Short-term mortality
25
Hospital days
Write a Comment
User Comments (0)
About PowerShow.com